These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2056118)

  • 41. RAS-blocking bisphosphonate zoledronic acid inhibits the abnormal proliferation and differentiation of juvenile myelomonocytic leukemia cells in vitro.
    Ohtsuka Y; Manabe A; Kawasaki H; Hasegawa D; Zaike Y; Watanabe S; Tanizawa T; Nakahata T; Tsuji K
    Blood; 2005 Nov; 106(9):3134-41. PubMed ID: 16046524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient mice.
    Iversen PO; Lewis ID; Turczynowicz S; Hasle H; Niemeyer C; Schmiegelow K; Bastiras S; Biondi A; Hughes TP; Lopez AF
    Blood; 1997 Dec; 90(12):4910-7. PubMed ID: 9389708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CBL mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia.
    Watanabe J; Sato K; Osawa Y; Horiuchi T; Kato S; Hikota-Saga R; Maekawa T; Yamamura T; Kobayashi A; Kobayashi S; Kimura F
    Int J Hematol; 2018 Jul; 108(1):47-57. PubMed ID: 29600428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic Leukemia.
    Geissler K; Jäger E; Barna A; Gurbisz M; Graf T; Graf E; Nösslinger T; Pfeilstöcker M; Machherndl-Spandl S; Stauder R; Zebisch A; Sill H; Öhler L; Kusec R; Hörmann G; Valent P
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of estradiol on human myelomonocytic cells. II. Mechanism of enhancing activity of colony formation.
    Barak V; Biran S; Halimi M; Treves AJ
    J Reprod Immunol; 1986 Dec; 9(4):355-63. PubMed ID: 3469412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin 4 potentiates the antiproliferative effect of 1 alpha, 25-dihydroxyvitamin D3 on mouse monocytic leukemia cells but antagonizes the antiproliferative effects of interferon alpha, beta and interleukin 6.
    Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M
    Leuk Res; 1992 Dec; 16(12):1191-6. PubMed ID: 1465028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase 1 study of lenzilumab, a recombinant anti-human GM-CSF antibody, for chronic myelomonocytic leukemia.
    Patnaik MM; Sallman DA; Mangaonkar AA; Heuer R; Hirvela J; Zblewski D; Al-Kali A; Binder M; Balasis ME; Newman H; Letson C; Kruer TL; Gangat N; Komrokji RS; Tefferi A; Lo A; Shih T; Durrant C; List AF; Padron E
    Blood; 2020 Aug; 136(7):909-913. PubMed ID: 32294158
    [No Abstract]   [Full Text] [Related]  

  • 48. Chronic myelomonocytic leukemia: from biology to therapy.
    Cambier N; Baruchel A; Schlageter MH; Menot ML; Wattel E; Fenaux P; Chomienne C
    Hematol Cell Ther; 1997 Apr; 39(2):41-8. PubMed ID: 9168299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-6 (IL-6) production and cell growth of cultured human ameningiomas:-interactions with interleukin-1 beta (IL-1 beta) and interleukin-4 (IL-4) in vitro.
    Boyle-Walsh E; Hashim IA; Speirs V; Fraser WD; White MC
    Neurosci Lett; 1994 Mar; 170(1):129-32. PubMed ID: 8041488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An antiproliferative bioassay for interleukin-4.
    Page LA; Topp MS; Thorpe R; Mire-Sluis AR
    J Immunol Methods; 1996 Jan; 189(1):129-35. PubMed ID: 8576574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unusual cutaneous lesions associated with chronic myelomonocytic leukaemia.
    Horiuchi Y; Masuzawa M; Nozaki O; Shibahara N; Shiga T; Yoshida M
    Clin Exp Dermatol; 1992 Mar; 17(2):121-4. PubMed ID: 1516236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-4 treatment reduces leukemia burden in acute myeloid leukemia.
    Qian F; Arner BE; Kelly KM; Annageldiyev C; Sharma A; Claxton DF; Paulson RF; Prabhu KS
    FASEB J; 2022 May; 36(5):e22328. PubMed ID: 35471732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner.
    Peña-Martínez P; Eriksson M; Ramakrishnan R; Chapellier M; Högberg C; Orsmark-Pietras C; Richter J; Andersson A; Fioretos T; Järås M
    Leukemia; 2018 Mar; 32(3):588-596. PubMed ID: 28819278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
    Obiri NI; Hillman GG; Haas GP; Sud S; Puri RK
    J Clin Invest; 1993 Jan; 91(1):88-93. PubMed ID: 8423237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells.
    Obiri NI; Siegel JP; Varricchio F; Puri RK
    Clin Exp Immunol; 1994 Jan; 95(1):148-55. PubMed ID: 8287600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergistic effect of IL-4 and TNF-alpha in the induction of monocytic differentiation of a mouse myeloid leukaemic cell line (WEHI-3B JCS).
    Leung KN; Mak NK; Fung MC; Hapel AJ
    Immunology; 1994 Jan; 81(1):65-72. PubMed ID: 8132222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth factors controlling interleukin-4 action on hematopoietic progenitors.
    Ferrajoli A; Zipf TF; Talpaz M; Felix EA; Estrov Z
    Ann Hematol; 1993 Dec; 67(6):277-84. PubMed ID: 7506581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells.
    Akashi K; Shibuya T; Harada M; Takamatsu Y; Uike N; Eto T; Niho Y
    J Clin Invest; 1991 Jul; 88(1):223-30. PubMed ID: 2056118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-4 stimulates the growth of chronic myelomonocytic leukemia cells (CMMoL) once leukemic transformation has occurred.
    Yanagisawa K; Hatta N; Watanabe I; Horiuchi T; Hasegawa H; Fujita S
    Leukemia; 1995 Jun; 9(6):1056-9. PubMed ID: 7596169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
    Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
    Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.